SAT-381 Rapid liver disease progression after first hepatic decompensation in individuals with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype)
Lorenz Balcar(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Malin Fromme, Martin Wagner(Medical University of Graz), Pavel Strnad(RWTH Aachen University), Benjamin Maasoumy(Medizinische Hochschule Hannover), Mònica Pons(Universitat Autònoma de Barcelona), Jef Verbeek(KU Leuven), Jan Stolk(Leiden University Medical Center), Hannah Schneider, Tammo Lambert Tergast(Medizinische Hochschule Hannover), Georg Semmler(University of Southern Denmark), Markus Peck‐Radosavljevic(Klinikum Klagenfurt), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Austrian Academy of Sciences), Jan Šperl(Institute of Clinical and Experimental Medicine), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Bart van Hoek(Leiden University Medical Center), Heinz Zoller(Universität Innsbruck), Naomi Kappe(Erasmus MC), Harald Hofer(Klinikum Wels-Grieskirchen), Sonèa Franèková, Natalie Van den Ende
Cited by 0
Related Papers
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k